Truvestments Capital’s DexCom DXCM Stock Holding History

Truvestments Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35K	Hold	20	–	–	﹤0.01%	1037
2026 Q1	$1.26K	Hold	20	–	–	﹤0.01%	1035
2025 Q4	$1.33K	Hold	20	–	–	﹤0.01%	908
2025 Q3	$1.35K	Hold	20	–	–	﹤0.01%	943
2025 Q2	$1.75K	Sell	20 -100	-83%	-$7.84K	﹤0.01%	856
2025 Q1	$8.2K	Hold	120	–	–	﹤0.01%	684
2024 Q4	$9.33K	Sell	120 -24	-17%	-$1.78K	﹤0.01%	619
2024 Q3	$9.65K	Buy	+144	New	+$11.8K	﹤0.01%	588
2024 Q1	–	Sell	-40	Closed	-$4.96K	–	765
2023 Q4	$4.96K	Hold	40	–	–	﹤0.01%	597
2023 Q3	$3.73K	Hold	40	–	–	﹤0.01%	539
2023 Q2	$5.14K	Hold	40	–	–	﹤0.01%	524
2023 Q1	$4.65K	Buy	+40	New	+$4.48K	﹤0.01%	520

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Truvestments Capital's DXCM Position: Q2 2026 in Review

Truvestments Capital held its DexCom (DXCM) position steady in Q2 2026 at 20 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Truvestments Capital first reported a position in DXCM in Q1 2023 and has held it in 12 quarters since. The position peaked at $9.65K in Q3 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Truvestments Capital held 20 shares of DexCom worth $1.35K as of Q2 2026.
Truvestments Capital left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1037 holding.
Truvestments Capital first reported a position in DexCom in Q1 2023 and has held it in 12 quarters since.
Truvestments Capital's DexCom position peaked at $9.65K in Q3 2024.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.